Ginkgo Bioworks Holdings, Inc.

BMV:DNA * Stock Report

Market Cap: Mex$9.4b

Ginkgo Bioworks Holdings Future Growth

Future criteria checks 0/6

Ginkgo Bioworks Holdings is forecast to grow earnings and revenue by 48.1% and 1.8% per annum respectively. EPS is expected to grow by 52.5% per annum. Return on equity is forecast to be -32.4% in 3 years.

Key information

48.1%

Earnings growth rate

52.5%

EPS growth rate

Chemicals earnings growth45.9%
Revenue growth rate1.8%
Future return on equity-32.4%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BMV:DNA * - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026246-189N/AN/A3
12/31/2025203-309N/AN/A6
12/31/2024228-522N/AN/A6
9/30/2024218-651-387-335N/A
6/30/2024184-898-347-305N/A
3/31/2024209-854-322-294N/A
12/31/2023251-893-336-295N/A
9/30/2023315-857-405-342N/A
6/30/2023326-1,224-369-297N/A
3/31/2023390-1,719-391-323N/A
12/31/2022478-2,105-304-252N/A
9/30/2022528-3,530-345-313N/A
6/30/2022539-2,962-314-290N/A
3/31/2022438-2,347-264-226N/A
12/31/2021314-1,830-310-254N/A
9/30/2021197-276-218-148N/A
6/30/2021133-200-262-168N/A
3/31/2021100-175-236-160N/A
12/31/202077-127-194-136N/A
12/31/201954-119-67-45N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DNA * is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: DNA * is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: DNA * is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: DNA *'s revenue (1.8% per year) is forecast to grow slower than the MX market (7.3% per year).

High Growth Revenue: DNA *'s revenue (1.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DNA * is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y